LONDON and CAMBRIDGE, MA--(Marketwire - September 18, 2009) -
Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive Officer, Glyn Edwards, will present an overview of the Company’s strategy, programmes and prospects at the UBS Global Life Sciences Conference in New York in New York City, on Wednesday, September 23rd at 14:30 EDT/19:30 BST.
A webcast of the presentation will be available on Antisoma’s website at http://www.antisoma.com/asm/media/webcast/
For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.
Enquiries: Alison Saville Senior Marketing and Communications Executive Antisoma plc +44 (0)20 3249 2100
Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com for further information about Antisoma.
---END OF MESSAGE---
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Copyright © Hugin AS 2009. All rights reserved.
